- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04148040
Per-oral Pyloromyotomy for Treating Infantile Hypertrophic Pyloric Stenosis
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Shanghai, China
- Recruiting
- Zhongshan Hospital
-
Contact:
- Quanlin Li
- Phone Number: 64041990
- Email: li.quanlin@zs-hospital.sh.cn
-
Contact:
- Zuqiang Liu
- Phone Number: 64041990
- Email: 16111210047@fudan.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of pyloric stenosis with or without sonographic confirmation.
Exclusion Criteria:
- Comorbid conditions that could affect postoperative recovery.
- Needed an additional procedure during the same anaesthetic.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: G-POEM for infantile hypertrophic pyloric stenosis
The procedure includes four steps: a) a transversal mucosal incision was performed at the proximal antrum.
b) a submucosal longitudinal tunnel was created across the pyloric ring.
c) full-thickness pyloromyotomy was performed, with a little extension of the antrum.
After pyloromyotomy, an ultrathin gastroscope was used to inspect the mucosa and pyloric outlet.
d) after careful hemostasis, the mucosal entry was closed by clips.
|
Per-oral pyloromyotomy (POP), also named as gastric per-oral endoscopic myotomy (G-POEM), for treating infantile hypertrophic pyloric stenosis (IHPS) has the following steps: mucosal incision, creation of submucosal tunnel, full-thickness pyloromyotomy, closure of the mucosal entry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
episodes of postoperative vomiting
Time Frame: 6 months after surgery
|
Primary outcomes included episodes of postoperative vomiting in times.
|
6 months after surgery
|
|
major complication
Time Frame: 6 months after surgery
|
Primary outcomes included major complication in times (based on lexicon and Clavien-Dindo classification, eg, vital-sign instability, ICU stay, hospital readmission, conversion to laparoscopic or open pyloromyotomy, invasive postoperative procedure, haemorrhage, blood transfusion, or prolonged hospitalization due to functional impairment).
|
6 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
operating and anaesthetic time
Time Frame: 6 months after surgery
|
Secondary outcomes included operating and anaesthetic time in minutes.
|
6 months after surgery
|
|
myotomy length
Time Frame: 6 months after surgery
|
Secondary outcomes included myotomy length in centimeters
|
6 months after surgery
|
|
other complications
Time Frame: 6 months after surgery
|
Secondary outcomes included other complications (yes or no) (eg, mucosal injury, delayed mucosal barrier failure, incomplete pyloromyotomy, and respiratory complications without invasive intervention).
|
6 months after surgery
|
|
postoperative pain assessment by "Pain assessment for children under four years"
Time Frame: 6 months after surgery
|
Secondary outcomes included postoperative pain assessment in score. This measurement chart is "Pain assessment for children under four years" which of pain scoring in the postoperative set up is: Cry (yes or no), Posture (relaxed or tense), Expression (relaxed, happy or distressed), Response when spoken to (yes or no). (Gupta A, Kaur K, Sharma S, Goyal S, Arora S, Murthy RS. Clinical aspects of acute post-operative pain management & its assessment. J Adv Pharm Technol Res. 2010;1(2):97-108.) |
6 months after surgery
|
|
analgesia requirements
Time Frame: 6 months after surgery
|
Secondary outcomes included analgesia requirements (yes or no).
|
6 months after surgery
|
|
time to full enteral feed
Time Frame: 6 months after surgery
|
Secondary outcomes included time to full enteral feed in hours.
|
6 months after surgery
|
|
postoperative length of stay
Time Frame: 6 months after surgery
|
Secondary outcomes included postoperative length of stay in days.
|
6 months after surgery
|
|
need for re-operation
Time Frame: 6 months after surgery
|
Secondary outcomes included need for re-operation (yes or no).
|
6 months after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Pinghong Zhou, Shanghai Zhongshan Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZSLQL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infantile Hypertrophic Pyloric Stenosis
-
Children's Mercy Hospital Kansas CityCompletedHypertrophic Pyloric StenosisUnited States
-
Sheba Medical CenterUniversity of HaifaUnknownHealthy | Hypertrophic Pyloric Stenosis
-
Bnai Zion Medical CenterUnknownSpinal Anesthesia | General Anesthesia | Hypertrophic Pyloric Stenosis
-
Centre Hospitalier Universitaire, AmiensRecruitingRespiratory Complication | Hypertrophic Pyloric StenosisFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingMiscellaneous Neoplasm, Nos | Non-Neoplastic Condition, NosUnited States
-
Universitätsklinikum Hamburg-EppendorfWuerzburg University Hospital; University of Kassel; University DüsseldorfRecruitingAdvanced Cancer, Various, NOSGermany
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingEBV-Positive Diffuse Large B-Cell Lymphoma, Nos | Brentuximab VedotinChina
-
University of California, San FranciscoSolving Kids' Cancer; Pediatric Neuro-Oncology ConsortiumRecruitingEmbryonal Tumor With Multilayered Rosettes | Embryonal Tumor With Multilayered Rosettes, NosUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); American Lebanese Syrian Associated CharitiesCompletedGlioblastoma Multiforme | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | DIPG | High-grade Astrocytoma NOS | CNS Primary Tumor, NOS (Malignant Glioma)United States
-
Bristol-Myers SquibbRecruiting
Clinical Trials on G-POEM
-
Maastricht University Medical CenterRecruiting
-
French Society of Digestive EndoscopyNot yet recruiting
-
University of ArkansasWithdrawn
-
Hvidovre University HospitalZealand University Hospital; Steno Diabetes Center CopenhagenRecruiting
-
Institute for Clinical and Experimental MedicineKing's College Hospital NHS Trust; Charles University, Czech Republic; Karolinska... and other collaboratorsCompletedGastroparesisUnited States, Czechia, Belgium, Denmark, Germany, Netherlands, Romania, Slovakia, Sweden, United Kingdom
-
AdventHealthMayo Clinic; University of South FloridaCompleted
-
Shanghai Zhongshan HospitalUnknownEsophageal AchalasiaChina
-
University of California, IrvineCedars-Sinai Medical Center; University of Ottawa; Hoag Memorial Hospital Presbyterian and other collaboratorsNot yet recruitingAchalasia, Esophageal | GERD (Gastroesophageal Reflux Disease)United States
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Johns Hopkins UniversityWithdrawnGastric StenosisUnited States